Main View
This view is used for searching all possible sources.
First Page Previous Page 1 Next Page Last Page
 
1
In Vivo Phospholipase Activity of the Pseudomonas aeruginosa Cytotoxin ExoU and Protection of Mammalian Cells with

of secreted phospho- lipase A2 enzymes or by a number of inhibitors of signal transduction pathways. This suggests that phospho- lipase A2 inhibitors may represent a novel mode of treat- ment for acute P response. The combined actions of ExoU as a cytotoxin and ExoT in its ability to inhibit ...

E-print Network

2
Adenosine A2A receptors in both bone marrow cells and non-bone marrow cells contribute to traumatic brain injury.
2010-03-29

Adenosine A2A receptors (A(2A)Rs) in bone marrow-derived cells (BMDCs) are involved in regulation of inflammation and outcome in several CNS injuries; however their relative contribution to traumatic brain injury (TBI) is unknown. In this study, we created a mouse cortical impact model, and BMDC ...

PubMed

3
A prostaglandin oligomeric derivative inhibits activities of phospholipase and protease: a possible mechanism of membrane protection during ischemia.
1989-01-01

A prostaglandin oligomeric derivative was synthesized by alkaline treatment of prostaglandin E1. This compound protected the perfused rat heart from global ischemia. This compound was found to inhibit several lipolytic and proteolytic enzymes in vitro. When phospholipase A2 from Naja naja venom was used as an ...

PubMed

4
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice.
1996-12-19

In previous work, we reported that chlorpromazine inhibits tumor necrosis factor (TNF) production in endotoxin lipopolysaccharide-treated mice, and protects against lipopolysaccharide toxicity. Chlorpromazine is used as an antipsychotic and has several effects on the central nervous system. It acts on different neurotransmitter receptors and has other ...

PubMed

5
Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.
1968-08-01

Antibody specific for viral neuraminidase can be demonstrated in mice following (i) pulmonary infection with influenza virus, (ii) immunization with ultraviolet-in-activated influenza virus, (iii) immunization with isolated neuraminidase of influenza A(2) virus, and (iv) passive immunization with sera of rabbits immunized with isolated ...

PubMed

6
Protective effects of a new specific thromboxane antagonist in arachidonate-induced sudden death.
1987-05-01

Sodium arachidonate (NaAr), at a dose of 2.0 mg/kg injected i.v., is uniformly lethal in rabbits within 5 min. This sudden death is typified by a precipitous drop in mean arterial blood pressure, a dramatic decrease in the circulating platelet count, and by a sharp rise in plasma thromboxane A2 (TxA2) ...

PubMed

First Page Previous Page 1 Next Page Last Page